GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VERA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Vera Therapeutics, Inc. stock price took a fall of -6.01% on Wednesday
(Updated on Apr 17, 2024)

Sell candidate since Apr 16, 2024 Loss -6.01% PDF

The Vera Therapeutics, Inc. stock price fell by -6.01% on the last day (Wednesday, 17th Apr 2024) from $42.57 to $40.01. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 6.60% from a day low at $40.01 to a day high of $42.65. The price has fallen in 6 of the last 10 days but is still up by 1.04% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -71 thousand shares and in total, 1 million shares were bought and sold for approximately $41.93 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 37.27% during the next 3 months and, with a 90% probability hold a price between $41.45 and $78.45 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VERA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vera Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $43.63 and $43.21. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -18.58%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Vera Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $34.51 and $33.64. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Vera Therapeutics, Inc. finds support just below today's level at $34.51. If this is broken, then the next support from accumulated volume will be at $33.64 and $30.18.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.64 between high and low, or 6.60%. For the last week, the stock has had daily average volatility of 10.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VERA) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Vera Therapeutics, Inc. to open at $40.89, and during the day (based on 14 day Average True Range), to move between $36.51 and $43.51, which gives a possible trading interval of +/-$3.50 (+/-8.76%) up or down from last closing price. If Vera Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 17.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $41.62 (4.02%) than the support at $34.51 (13.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Vera Therapeutics, Inc. stock A Buy?

The Vera Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Vera Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.276 Sell Candidate Unchanged

Predicted Opening Price for Vera Therapeutics, Inc. of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$40.89 ( 2.20%) $40.01

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VERA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 43.53 8.80 %
R2 42.52 6.28 %
R1 41.90 4.72 %
Current price: 40.01
Support S1 39.88 -0.321 %
S2 39.26 -1.88 %
S3 38.25 -4.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 48.82 22.02 %
R2 47.97 19.90 %
R1 41.62 4.02 %
Current price 40.01
Support S1 34.51 -13.75%
S2 33.64 -15.92%
S3 30.18 -24.57%

FAQ

What is the symbol for Vera Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Vera Therapeutics, Inc. is VERA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vera Therapeutics, Inc. Stock?
The Vera Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Vera Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Vera Therapeutics, Inc. Stock?
Vera Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vera Therapeutics, Inc. Stock.

What's the current price of Vera Therapeutics, Inc. Stock?
As of the end of day on the 2024-04-17, the price of an Vera Therapeutics, Inc. (VERA) share was $40.01.

What is the 52-week high and low for Vera Therapeutics, Inc. Stock?
The 52-week high for Vera Therapeutics, Inc. Stock is $50.69 and the 52-week low is $6.07.

What is the market capitalization of Vera Therapeutics, Inc. Stock?
As of the 2024-04-17, the market capitalization of Vera Therapeutics, Inc. is 2.338B.

When is the next earnings date for Vera Therapeutics, Inc.?
The upcoming earnings date for Vera Therapeutics, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Vera Therapeutics, Inc.

Vera Therapeutics. Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of ... VERA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT